The sale, approved in bankruptcy court and orchestrated by 23andMe’s former CEO Anne Wojcicki, risks stripping millions of Californians of their right to control their DNA data. “This is one of the ...

Through genetic testing, millions of Americans are estimated to have discovered that their parents aren’t who they thought.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...